SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
TYRA

Tyra Biosciences, Inc. (TYRA)

United States · Delayed Price · Currency is USD
Pharmaceutical Preparations
20.71+0.26 (+1.27%)
 
Insider Score
Insider Score
/ 100
TYRA Insider Score

Tyra Biosciences, Inc. has a live Insider Score.

Scored on 1 qualifying trade from 1 insider in the last 90 days.

Unlock the score

TYRA analyst forecast

TYRA analyst consensus

Moderate Buy3 ratings
Buy 3 Hold 0 Sell 0

Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.

TYRA 12-month price target

$53.00+156.5% upsideaverage of 2 firms
$56.00High
$50.00Low

Best analysts covering TYRA

  • Jefferies100%success rate · 1 call
  • HC Wainwright & Co.59%success rate · 22 calls
  • Oppenheimer33%success rate · 6 calls
  • Wedbush29%success rate · 7 calls

Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.

TYRA analyst ratings

FirmPrice targetAction
Raymond James—$50.00+138.9%—2026-10-06
—HC Wainwright & Co.Buy——Reiterated2026-09-22
—OppenheimerOutperform——Reiterated2026-09-22
—WedbushOutperform——Reiterated2026-09-10
—HC Wainwright & Co.Buy——Reiterated2026-09-10
Piper Sandler—$56.00+95.1%—2026-09-08
—HC Wainwright & Co.Buy——Reiterated2026-09-04
—B of A SecuritiesBuy——Reiterated2026-06-10
—HC Wainwright & Co.Buy——Reiterated2026-05-14
—Piper SandlerOverweight——Reiterated2026-03-20
—HC Wainwright & Co.Buy——Reiterated2026-02-17
—WedbushOutperform——Reiterated2026-02-13
—OppenheimerOutperform——Reiterated2026-02-03
—JefferiesBuy——Reiterated2026-02-03
—Piper SandlerOverweight——Reiterated2026-01-23
—WedbushOutperform——Reiterated2025-12-16
—HC Wainwright & Co.Buy——Reiterated2025-08-22
—HC Wainwright & Co.Buy——Reiterated2025-07-01
—HC Wainwright & Co.Buy——Reiterated2025-03-31
—HC Wainwright & Co.Buy——Reiterated2025-02-18
—HC Wainwright & Co.Buy——Reiterated2025-01-13
—HC Wainwright & Co.Buy——Reiterated2024-11-11
—HC Wainwright & Co.Buy——Reiterated2024-10-29
—HC Wainwright & Co.Buy——Reiterated2024-10-28
—WedbushOutperform——Reiterated2024-10-25
—B of A SecuritiesBuy——Upgraded2024-10-18
—HC Wainwright & Co.Buy——Reiterated2024-10-07
—OppenheimerOutperform——Reiterated2024-09-19
—WedbushOutperform——Reiterated2024-08-08
—OppenheimerOutperform——Reiterated2024-08-08
—HC Wainwright & Co.Buy——Reiterated2024-07-03
—OppenheimerOutperform——Reiterated2024-07-03
—WedbushOutperform——Reiterated2024-07-03
—HC Wainwright & Co.Buy——Reiterated2024-06-05
—OppenheimerOutperform——Reiterated2024-05-13
—HC Wainwright & Co.Buy——Reiterated2024-05-10
—WedbushOutperform——Reiterated2024-05-10
—WedbushOutperform——Reiterated2024-03-21
—HC Wainwright & Co.Buy——Reiterated2024-03-20
—WedbushOutperform——Reiterated2023-12-29
—HC Wainwright & Co.Buy——Reiterated2023-12-26
—HC Wainwright & Co.Buy——Reiterated2023-11-08
—WedbushOutperform——Reiterated2023-08-11
—HC Wainwright & Co.Buy——Reiterated2023-08-11
—HC Wainwright & Co.Buy——Reiterated2023-08-01
—OppenheimerOutperform——Reiterated2023-05-08
—HC Wainwright & Co.Buy——Reiterated2023-05-05
—HC Wainwright & Co.Buy——Reiterated2023-03-23
—HC Wainwright & Co.Buy——Reiterated2023-03-07
—HC Wainwright & Co.Buy——Reiterated2023-03-02
—OppenheimerOutperform——Reiterated2023-02-03
—HC Wainwright & Co.Buy——Reiterated2022-06-23
—JefferiesBuy——Upgraded2022-03-08
—JefferiesHold——Downgraded2021-11-08
—Cowen & Co.Outperform——Reiterated2021-10-11
—B of A SecuritiesBuy——Reiterated2021-10-11
—JefferiesBuy——Reiterated2021-10-11

TYRA earnings vs. estimates

QuarterEPS est.EPS actualRevenue est.Revenue actual
2026-03-02-0.54-0.57$0$0
2026-05-13-0.60-0.64$0$0
2026-08-04-0.65-0.69$0$0
2026-11-04-0.670.00$0$0
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.